High expression of HMBOX1 contributes to poor prognosis of gastric cancer by promoting cell proliferation and migration - 09/06/19
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 9 |
| Iconographies | 5 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Homeobox-containing 1 (HMBOX1) has been reported to be associated with biological characteristics of some tumors, but its roles in gastric cancer have never been reported. In the present study, we found that HMBOX1 expression was significantly upregulated in gastric cancer tissues and cell lines and correlated with the TNM stage, lymph-node metastatic and the overall survival (OS) of patients of gastric cancer. The overexpression of HMBOX1 in gastric cancer cells enhanced cell proliferation by accelerating cell cycle, induced cell migration. In contrast, silencing HMBOX1 inhibited these processes. And the expression of HMBOX1 was related with the expression of vascular endothelial growth factor receptor (VEGFR), transforming growth factor-β (TGF-β) and CD133. What’s more, we found that the expression of CD133 had a significantly positive correlation with HMBOX1 in gastric cancer tissues, and the co-expression of HMBOX1 and CD133 was significantly correlated with poor prognosis of gastric cancer patients, especially for patients at III and IV stage. In conclusion, HMBOX1 was upregulated in gastric cancer and correlated with gastric cancer cell proliferation and migration. Moreover, HMBOX1 combined CD133 might be useful to predict survival of patients with advanced gastric cancer.
Le texte complet de cet article est disponible en PDF.Abbreviations : HMBOX1, OS, VEGFR, TGF-β, GES-1, TNM, Q-PCR, FCM, CSCs
Keywords : HMBOX1, Gastric cancer, Proliferation, Migration, Cell cycle, CD133
Plan
Vol 115
Article 108867- juillet 2019 Retour au numéro
Article précédent
- Preliminary studies on the anti-osteoporosis activity of Baohuoside I
- Yanhai Xi, Tingwang Jiang, Jiangming Yu, Mintao Xue, Ning Xu, Jiankun Wen, Weiheng Wang, Hailong He, Xiaojian Ye
- Imatinib-induced changes in the expression profile of microRNA in the plasma and heart of mice—A comparison with doxorubicin
- Barbora Hanousková, Mikuláš Skála, Veronika Brynychová, Tomáš Zárybnický, Veronika Skarková, Petra Kazimírová, Andrea Vernerová, Pavel Sou?ek, Lenka Skálová, Radek Pudil, Petra Matoušková
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?